A common problem in the cannabis edibles industry is ensuring a strain’s many properties are preserved during the process of turning flower or oil into consumable products. But one Seattle-based firm is aiming to become a trailblazer in what’s called “lossless activation.”
Those online pop-ups age-gating requests on sites from licensed producer and retail stores inspired Cannvas.Me to investigate if that demographic data can help those businesses learn more about their customers.
Robust is one way to define the current breadth of research that involves the cannabis and its chemical parts. Across the planet – namely in states and countries where medical cannabis is permitted – scientists are becoming increasingly invested in discovering the full potential of the cannabis plant.
If you know anything about cannabis science, you know the name Dr. Raphael Mechoulam. The Israeli cannabis researcher is a specialist in the chemistry and pharmacology of cannabinoids. Mechoulam, now 88, is known as the first researcher to identify THC as the psychoactive compound within cannabis. He’s been analyzing cannabis compounds for a whopping 50 years. We caught up with Mechoulam recently to discuss the next big cannabinoids, the future of cannabis research, and his revered career in the...
This website offers education and information on cannabis and related products, and is restricted to adults aged and older, or valid medical cannabis patients. Please enter your birthdate.
Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.